NSF International to offer Secondary Reference Standards in India NSF International to offer Secondary Reference Standards in India Hires additional India-based business development staff to meet increased demand NicOx appoints three commercial executives in the US NicOx appoints three commercial executives in the US In preparation for the launch of ophthalmic product AdenoPlus NextPharma makes three appointments NextPharma makes three appointments Two additions to executive team and vp of sales and marketing in US Roche makes changes to corporate executive committee Roche makes changes to corporate executive committee Daniel O’Day becomes head of Roche Pharma and Roland Diggelmann head of Roche Diagnostics AstraZeneca appoints chief executive AstraZeneca appoints chief executive Pascal Soriot joins the firm on 1 October Lundbeck makes two appointments Lundbeck makes two appointments Commercial senior vice president and vice president Hovione appoints drug product development director Hovione appoints drug product development director Former Merck and Xenon Pharmaceuticals director joins the firm Mariana Kuras joins Ariana Pharma Mariana Kuras joins Ariana Pharma Takes the position of chief technology officer Early phase team expansion at RSSL Early phase team expansion at RSSL Steve Alley joins the firm as a senior scientist David Bardsley joins Cresset Group David Bardsley joins Cresset Group Takes newly created role of sales director Avantor Performance Materials names new president and ceo Avantor Performance Materials names new president and ceo Chemical industry veteran John Steitz to lead performance materials supplier Newman Labelling appoints new production manager Newman Labelling appoints new production manager Promotes Martyn Bell to the position Dr Karl Keegan to join Vectura Group Dr Karl Keegan to join Vectura Group Will take responsibility for corporate development and investor relations Astellas Pharma Europe promotes Dr Susan Wood Astellas Pharma Europe promotes Dr Susan Wood She becomes senior director, market access Ashland looks for growth Ashland looks for growth Appoints group vp of technology growth and strategy Donald Brydon to become chairman of MRC on 1 October Donald Brydon to become chairman of MRC on 1 October The appointment is for four years